OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Melflufen for the treatment of multiple myeloma
Enrique M. Ocio, Omar Nadeem, Fredrik Schjesvold, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 4, pp. 371-382
Closed Access | Times Cited: 5
Enrique M. Ocio, Omar Nadeem, Fredrik Schjesvold, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 4, pp. 371-382
Closed Access | Times Cited: 5
Showing 5 citing articles:
Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment
Tiansi Wang, Meichai Li, Ruting Wei, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1038-1055
Closed Access | Times Cited: 6
Tiansi Wang, Meichai Li, Ruting Wei, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1038-1055
Closed Access | Times Cited: 6
Anti-Angiogenic Activity of Drugs in Multiple Myeloma
Ilaria Saltarella, Concetta Altamura, Carmen Campanale, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1990-1990
Open Access | Times Cited: 11
Ilaria Saltarella, Concetta Altamura, Carmen Campanale, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1990-1990
Open Access | Times Cited: 11
PORT: A Randomized, Cross-over, Phase 2 Study of Melflufen Peripheral versus Central Intravenous Administration in Patients with Relapsed/Refractory Multiple Myeloma
Luděk Pour, Ilina Micheva, Ganna Usenko, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 6, pp. e267-e275.e2
Open Access | Times Cited: 1
Luděk Pour, Ilina Micheva, Ganna Usenko, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 6, pp. e267-e275.e2
Open Access | Times Cited: 1
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide
Clifton C. Mo, Edward Richardson, Eleonora Calabretta, et al.
Blood Reviews (2024) Vol. 66, pp. 101218-101218
Open Access | Times Cited: 1
Clifton C. Mo, Edward Richardson, Eleonora Calabretta, et al.
Blood Reviews (2024) Vol. 66, pp. 101218-101218
Open Access | Times Cited: 1
Recent Progress in the Development of Peptide-Drug Conjugates (PDCs) for Cancer Therapy
Haiqi He, Xin Deng, Zhijie Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117204-117204
Closed Access | Times Cited: 1
Haiqi He, Xin Deng, Zhijie Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117204-117204
Closed Access | Times Cited: 1
